Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy

Xue Yang, Huipeng Li, Chenggen Qian, Yuxin Guo, Chenzi Li, Fang Gao, Ying Yang, Kaikai Wang, David Oupicky, Minjie Sun

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Tumor angiogenesis is a key step in the process of tumor development, and antitumor angiogenesis has a profound influence on tumor growth. Herein we report a dual-function drug delivery system comprising a Near-infrared (NIR) dye and an anti-angiogenic drug within liposomes (Lip-IR780-Sunitinib) for enhanced antitumor therapy. The hydrophobic NIR dye IR780 was loaded into the liposome phospholipid bilayer, and the bilayer would be disrupted by laser irradiation so that anti-angiogenic drug sunitinib release would be activated remotely at the tumor site. The released hydrophilic sunitinib could potentially target multiple VEGF receptors on the tumor endothelial cell surface to inhibit angiogenesis. Meanwhile, IR780-loaded liposomes kill the cancer cells by photothermal therapy. Lip-IR780-Sunitinib exhibited enhanced anti-tumor and anti-angiogenic effects in vitro and in vivo. This system facilitates easy and controlled release of cargos to achieve anti-tumor angiogenesis and photothermal therapy.

Original languageEnglish (US)
Pages (from-to)2283-2294
Number of pages12
JournalNanomedicine: Nanotechnology, Biology, and Medicine
Volume14
Issue number7
DOIs
StatePublished - Oct 1 2018

Fingerprint

Liposomes
Tumors
Infrared radiation
Light
Neoplasms
Angiogenesis Inhibitors
Therapeutics
Lip
Coloring Agents
Dyes
Vascular Endothelial Growth Factor Receptor
Phospholipids
Endothelial cells
Laser beam effects
Drug Delivery Systems
Cell- and Tissue-Based Therapy
Cells
Lasers
Endothelial Cells
sunitinib

Keywords

  • Anti-angiogenesis
  • Drug delivery
  • Near-infrared light
  • Photothermal therapy

ASJC Scopus subject areas

  • Bioengineering
  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biomedical Engineering
  • Materials Science(all)
  • Pharmaceutical Science

Cite this

Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy. / Yang, Xue; Li, Huipeng; Qian, Chenggen; Guo, Yuxin; Li, Chenzi; Gao, Fang; Yang, Ying; Wang, Kaikai; Oupicky, David; Sun, Minjie.

In: Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 14, No. 7, 01.10.2018, p. 2283-2294.

Research output: Contribution to journalArticle

Yang, Xue ; Li, Huipeng ; Qian, Chenggen ; Guo, Yuxin ; Li, Chenzi ; Gao, Fang ; Yang, Ying ; Wang, Kaikai ; Oupicky, David ; Sun, Minjie. / Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy. In: Nanomedicine: Nanotechnology, Biology, and Medicine. 2018 ; Vol. 14, No. 7. pp. 2283-2294.
@article{7c13640199ac40d68c1a1be64ce48ead,
title = "Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy",
abstract = "Tumor angiogenesis is a key step in the process of tumor development, and antitumor angiogenesis has a profound influence on tumor growth. Herein we report a dual-function drug delivery system comprising a Near-infrared (NIR) dye and an anti-angiogenic drug within liposomes (Lip-IR780-Sunitinib) for enhanced antitumor therapy. The hydrophobic NIR dye IR780 was loaded into the liposome phospholipid bilayer, and the bilayer would be disrupted by laser irradiation so that anti-angiogenic drug sunitinib release would be activated remotely at the tumor site. The released hydrophilic sunitinib could potentially target multiple VEGF receptors on the tumor endothelial cell surface to inhibit angiogenesis. Meanwhile, IR780-loaded liposomes kill the cancer cells by photothermal therapy. Lip-IR780-Sunitinib exhibited enhanced anti-tumor and anti-angiogenic effects in vitro and in vivo. This system facilitates easy and controlled release of cargos to achieve anti-tumor angiogenesis and photothermal therapy.",
keywords = "Anti-angiogenesis, Drug delivery, Near-infrared light, Photothermal therapy",
author = "Xue Yang and Huipeng Li and Chenggen Qian and Yuxin Guo and Chenzi Li and Fang Gao and Ying Yang and Kaikai Wang and David Oupicky and Minjie Sun",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.nano.2018.06.011",
language = "English (US)",
volume = "14",
pages = "2283--2294",
journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",
issn = "1549-9634",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Near-infrared light-activated IR780-loaded liposomes for anti-tumor angiogenesis and Photothermal therapy

AU - Yang, Xue

AU - Li, Huipeng

AU - Qian, Chenggen

AU - Guo, Yuxin

AU - Li, Chenzi

AU - Gao, Fang

AU - Yang, Ying

AU - Wang, Kaikai

AU - Oupicky, David

AU - Sun, Minjie

PY - 2018/10/1

Y1 - 2018/10/1

N2 - Tumor angiogenesis is a key step in the process of tumor development, and antitumor angiogenesis has a profound influence on tumor growth. Herein we report a dual-function drug delivery system comprising a Near-infrared (NIR) dye and an anti-angiogenic drug within liposomes (Lip-IR780-Sunitinib) for enhanced antitumor therapy. The hydrophobic NIR dye IR780 was loaded into the liposome phospholipid bilayer, and the bilayer would be disrupted by laser irradiation so that anti-angiogenic drug sunitinib release would be activated remotely at the tumor site. The released hydrophilic sunitinib could potentially target multiple VEGF receptors on the tumor endothelial cell surface to inhibit angiogenesis. Meanwhile, IR780-loaded liposomes kill the cancer cells by photothermal therapy. Lip-IR780-Sunitinib exhibited enhanced anti-tumor and anti-angiogenic effects in vitro and in vivo. This system facilitates easy and controlled release of cargos to achieve anti-tumor angiogenesis and photothermal therapy.

AB - Tumor angiogenesis is a key step in the process of tumor development, and antitumor angiogenesis has a profound influence on tumor growth. Herein we report a dual-function drug delivery system comprising a Near-infrared (NIR) dye and an anti-angiogenic drug within liposomes (Lip-IR780-Sunitinib) for enhanced antitumor therapy. The hydrophobic NIR dye IR780 was loaded into the liposome phospholipid bilayer, and the bilayer would be disrupted by laser irradiation so that anti-angiogenic drug sunitinib release would be activated remotely at the tumor site. The released hydrophilic sunitinib could potentially target multiple VEGF receptors on the tumor endothelial cell surface to inhibit angiogenesis. Meanwhile, IR780-loaded liposomes kill the cancer cells by photothermal therapy. Lip-IR780-Sunitinib exhibited enhanced anti-tumor and anti-angiogenic effects in vitro and in vivo. This system facilitates easy and controlled release of cargos to achieve anti-tumor angiogenesis and photothermal therapy.

KW - Anti-angiogenesis

KW - Drug delivery

KW - Near-infrared light

KW - Photothermal therapy

UR - http://www.scopus.com/inward/record.url?scp=85052005784&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052005784&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2018.06.011

DO - 10.1016/j.nano.2018.06.011

M3 - Article

VL - 14

SP - 2283

EP - 2294

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

SN - 1549-9634

IS - 7

ER -